The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

Reino Heikkilä, G Schwab, Eric Wickstrom et al. · Nature · 1987 · 691 citations

Life Sciences, Genetics, Molecular Biology +14

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.

Teresa L. Burgess, Eric F. Fisher, Sandra L. Ross et al. · Proceedings of the National Academy of Sciences · 1995 · 322 citations · Full text

Medicine, Molecular Biology, Pharmacology +16

c‐myc down‐regulates class I HLA expression in human melanomas.

Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters et al. · The EMBO Journal · 1988 · 254 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Down-regulation of LFA-1 Adhesion Receptors by C- <i>myc</i> Oncogene in Human B Lymphoblastoid Cells

Giorgio Inghirami, F Grignani, Lars Sternås et al. · Science · 1990 · 135 citations

Life Sciences, Cell Biology, Molecular Biology +16

ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation

Xin Lü, Sang Hee Park, Timothy C. Thompson et al. · Cell · 1992 · 134 citations

Medicine, Genetics, Oncology +14